Evaluating pathogenic dementia variants in posterior cortical atrophy

Neurobiology of Aging

Volumn 37, Issue , 2016, Pages 38-44

  Carrasquillo, Minerva M ^a   Barber, Imelda ^b   Lincoln, Sarah J ^a   Murray, Melissa E ^a   Camsari, Gamze Balci ^c   Khan, Qurat ul Ain ^c   Nguyen, Thuy ^a   Ma, Li ^a   Bisceglio, Gina D ^a   Crook, Julia E ^c   Younkin, Steven G ^a   Dickson, Dennis W ^a   Boeve, Bradley F ^d   Graff Radford, Neill R ^c   Morgan, Kevin ^b   Ertekin Taner, Nilüfer ^a,c  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c MAYO CLINIC   (United States)

^d MAYO CLINIC   (United States)

Author keywords

APOE; Dementia; NeuroX; PCA; Posterior Alzheimer's disease; PSEN2; TREM2

Indexed keywords

APOLIPOPROTEIN E4; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; PRESENILIN 2; PSEN2 PROTEIN, HUMAN; TREM2 PROTEIN, HUMAN;

ARTICLE; BRAIN CORTEX ATROPHY; DEMENTIA; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FRONTOTEMPORAL DEMENTIA; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRION DISEASE; PRIORITY JOURNAL; PSEN2 GENE; TREM2 GENE; ADULT; AGED; ALZHEIMER DISEASE; COHORT ANALYSIS; EXOME; FEMALE; GENETICS; GENOTYPING TECHNIQUE; MALE; MIDDLE AGED; MUTATION; PROCEDURES; SYNDROME; VERY ELDERLY; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COHORT STUDIES; EXOME; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MUTATION; PRESENILIN-2; RECEPTORS, IMMUNOLOGIC; SYNDROME; VISION DISORDERS;

EID: 84957583628     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.09.023     Document Type: Article

References (38)

1. Adzhubei, I., Jordan, D.M., Sunyaev, S.R., 2013. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. Chapter 7, Supplement 76, 7.20.1-7.20.41. http://dx.doi.org/10.1002/0471142905.hg0720s76.
2. Ala, T.A., Frey 2nd, W.H., Clark, H.B., 1996. Posterior cortical atrophy: neuropathological correlations. Arch. Neurol. 53, 958.
3. Alladi, S., Xuereb, J., Bak, T., Nestor, P., Knibb, J., Patterson, K., Hodges, J.R., 2007. Focal cortical presentations of Alzheimer's disease. Brain 130 (Pt 10), 2636-2645.
4. Barrett, J.C., 2009. Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb. Protoc. 2009, pdb ip71.
5. Benson, D.F., Davis, R.J., Snyder, B.D., 1988. Posterior cortical atrophy. Arch. Neurol. 45, 789-793.
6. Carney, R.M., Kohli, M.A., Kunkle, B.W., Naj, A.C., Gilbert, J.R., Zuchner, S., Pericak-Vance, M.A., 2014. Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation. Alzheimers Dement. 10, 360-365.
7. Caroppo, P., Belin, C., Grabli, D., Maillet, D., De Septenville, A., Migliaccio, R., Clot, F., Lamari, F., Camuzat, A., Brice, A., Dubois, B., Le Ber, I., 2015. Posterior cortical atrophy as an extreme phenotype of GRN mutations. JAMA Neurol. 72, 224-228.
8. Carrasquillo, M.M., Khan, Q., Murray, M.E., Krishnan, S., Aakre, J., Pankratz, V.S., Nguyen, T., Ma, L., Bisceglio, G., Petersen, R.C., Younkin, S.G., Dickson, D.W., Boeve, B.F., Graff-Radford, N.R., Ertekin-Taner, N., 2014. Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD. Neurology 82, 1455-1462.
9. Crutch, S.J., Lehmann, M., Schott, J.M., Rabinovici, G.D., Rossor, M.N., Fox, N.C., 2012. Posterior cortical atrophy. Lancet Neurol. 11, 170-178.
10. Cruts, M., Theuns, J., Van Broeckhoven, C., 2012. Locus-specific mutation databases for neurodegenerative brain diseases. Hum. Mutat. 33, 1340-1344.
11. Depaz, R., Haik, S., Peoc'h, K., Seilhean, D., Grabli, D., Vicart, S., Sarazin, M., DeToffol, B., Remy, C., Fallet-Bianco, C., Laplanche, J.L., Fontaine, B., Brandel, J.P., 2012. Long-standing prion dementia manifesting as posterior cortical atrophy. Alzheimer Dis. Assoc. Disord. 26, 289-292.
12. de Souza, L.C., Corlier, F., Habert, M.O., Uspenskaya, O., Maroy, R., Lamari, F., Chupin, M., Lehericy, S., Colliot, O., Hahn-Barma, V., Samri, D., Dubois, B., Bottlaender, M., Sarazin, M., 2011. Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease. Brain 134 (Pt 7), 2036-2043.
13. Ghani, M., Lang, A.E., Zinman, L., Nacmias, B., Sorbi, S., Bessi, V., Tedde, A., Tartaglia, M.C., Surace, E.I., Sato, C., Moreno, D., Xi, Z., Hung, R., Nalls, M.A., Singleton, A., St George-Hyslop, P., Rogaeva, E., 2015. Mutation analysis of patients with neurodegenerative disorders using NeuroX array. Neurobiol. Aging 36, 545.e9-545.e14.
14. Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, R., Rosser, M., Owen, M., Hardy, J., 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
15. Grove, M.L., Yu, B., Cochran, B.J., Haritunians, T., Bis, J.C., Taylor, K.D., Hansen, M., Borecki, I.B., Cupples, L.A., Fornage, M., Gudnason, V., Harris, T.B., Kathiresan, S., Kraaij, R., Launer, L.J., Levy, D., Liu, Y., Mosley, T., Peloso, G.M., Psaty, B.M., Rich, S.S., Rivadeneira, F., Siscovick, D.S., Smith, A.V., Uitterlinden, A., van Duijn, C.M., Wilson, J.G., O'Donnell, C.J., Rotter, J.I., Boerwinkle, E., 2013. Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One 8, e68095.
16. Guerreiro, R., Bras, J., Wojtas, A., Rademakers, R., Hardy, J., Graff-Radford, N., 2014. A nonsense mutation in PRNP associated with clinical Alzheimer's disease. Neurobiol. Aging 35, 2656.e13-2656.e16.
17. Guerreiro, R., Hardy, J., 2013. TREM2 and neurodegenerative disease. N. Engl. J. Med. 369, 1569-1570.
18. Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P.V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A.I., Lah, J.J., Rujescu, D., Hampel, H., Giegling, I., Andreassen, O.A., Engedal, K., Ulstein, I., Djurovic, S., Ibrahim-Verbaas, C., Hofman, A., Ikram, M.A., van Duijn, C.M., Thorsteinsdottir, U., Kong, A., Stefansson, K., 2013. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107-116.
19. Kleinberger, G., Yamanishi, Y., Suarez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., Tahirovic, S., Lleo, A., Alcolea, D., Fortea, J., Willem, M., Lammich, S., Molinuevo, J.L., Sanchez-Valle, R., Antonell, A., Ramirez, A., Heneka, M.T., Sleegers, K., van der Zee, J., Martin, J.J., Engelborghs, S., Demirtas-Tatlidede, A., Zetterberg, H., Van Broeckhoven, C., Gurvit, H., Wyss-Coray, T., Hardy, J., Colonna, M., Haass, C., 2014. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci. Transl. Med. 6, 243ra86.
20. Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., Jun, G., Destefano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., Russo, G., Thornton-Wells, T.A., Jones, N., Smith, A.V., Chouraki, V., Thomas, C., Ikram, M.A., Zelenika, D., Vardarajan, B.N., Kamatani, Y., Lin, C.F., Gerrish, A., Schmidt, H., Kunkle, B., Dunstan, M.L., Ruiz, A., Bihoreau, M.T., Choi, S.H., Reitz, C., Pasquier, F., Hollingworth, P., Ramirez, A., Hanon, O., Fitzpatrick, A.L., Buxbaum, J.D., Campion, D., Crane, P.K., Baldwin, C., Becker, T., Gudnason, V., Cruchaga, C., Craig, D., Amin, N., Berr, C., Lopez, O.L., De Jager, P.L., Deramecourt, V., Johnston, J.A., Evans, D., Lovestone, S., Letenneur, L., Moron, F.J., Rubinsztein, D.C., Eiriksdottir, G., Sleegers, K., Goate, A.M., Fievet, N., Huentelman, M.J., Gill, M., Brown, K., Kamboh, M.I., Keller, L., Barberger-Gateau, P., McGuinness, B., Larson, E.B., Green, R., Myers, A.J., Dufouil, C., Todd, S., Wallon, D., Love, S., Rogaeva, E., Gallacher, J., St George-Hyslop, P., Clarimon, J., Lleo, A., Bayer, A., Tsuang, D.W., Yu, L., Tsolaki, M., Bossu, P., Spalletta, G., Proitsi, P., Collinge, J., Sorbi, S., Sanchez-Garcia, F., Fox, N.C., Hardy, J., Naranjo, M.C., Bosco, P., Clarke, R., Brayne, C., Galimberti, D., Mancuso, M., Matthews, F., Moebus, S., Mecocci, P., Del Zompo, M., Maier, W., Hampel, H., Pilotto, A., Bullido, M., Panza, F., Caffarra, P., Nacmias, B., Gilbert, J.R., Mayhaus, M., Lannfelt, L., Hakonarson, H., Pichler, S., Carrasquillo, M.M., Ingelsson, M., Beekly, D., Alvarez, V., Zou, F., Valladares, O., Younkin, S.G., Coto, E., Hamilton-Nelson, K.L., Gu, W., Razquin, C., Pastor, P., Mateo, I., Owen, M.J., Faber, K.M., Jonsson, P.V., Combarros, O., O'Donovan, M.C., Cantwell, L.B., Soininen, H., Blacker, D., Mead, S., Mosley Jr., T.H., Bennett, D.A., Harris, T.B., Fratiglioni, L., Holmes, C., de Bruijn, R.F., Passmore, P., Montine, T.J., Bettens, K., Rotter, J.I., Brice, A., Morgan, K., Foroud, T.M., Kukull, W.A., Hannequin, D., Powell, J.F., Nalls, M.A., Ritchie, K., Lunetta, K.L., Kauwe, J.S., Boerwinkle, E., Riemenschneider, M., Boada, M., Hiltunen, M., Martin, E.R., Schmidt, R., Rujescu, D., Wang, L.S., Dartigues, J.F., Mayeux, R., Tzourio, C., Hofman, A., Nothen, M.M., Graff, C., Psaty, B.M., Jones, L., Haines, J.L., Holmans, P.A., Lathrop, M., Pericak-Vance, M.A., Launer, L.J., Farrer, L.A., van Duijn, C.M., Van Broeckhoven, C., Moskvina, V., Seshadri, S., Williams, J., Schellenberg, G.D., Amouyel, P., 2013. Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45, 1452-1458.
21. Lehmann, M., Ghosh, P.M., Madison, C., Laforce Jr., R., Corbetta-Rastelli, C., Weiner, M.W., Greicius, M.D., Seeley, W.W., Gorno-Tempini, M.L., Rosen, H.J., Miller, B.L., Jagust, W.J., Rabinovici, G.D., 2013. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain 136 (Pt 3), 844-858.
22. Nalls, M.A., Bras, J., Hernandez, D.G., Keller, M.F., Majounie, E., Renton, A.E., Saad, M., Jansen, I., Guerreiro, R., Lubbe, S., Plagnol, V., Gibbs, J.R., Schulte, C., Pankratz, N., Sutherland, M., Bertram, L., Lill, C.M., DeStefano, A.L., Faroud, T., Eriksson, N., Tung, J.Y., Edsall, C., Nichols, N., Brooks, J., Arepalli, S., Pliner, H., Letson, C., Heutink, P., Martinez, M., Gasser, T., Traynor, B.J., Wood, N., Hardy, J., Singleton, A.B., 2015. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases. Neurobiol. Aging 36, 1605.e7-1605.e12.
23. Perry, D.C., Lehmann, M., Yokoyama, J.S., Karydas, A., Lee, J.J., Coppola, G., Grinberg, L.T., Geschwind, D., Seeley, W.W., Miller, B.L., Rosen, H., Rabinovici, G., 2013. Progranulin mutations as risk factors for Alzheimer disease. JAMA Neurol. 70, 774-778.
24. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J., Sham, P.C., 2007. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575.
25. Renner, J.A., Burns, J.M., Hou, C.E., McKeel Jr., D.W., Storandt, M., Morris, J.C., 2004. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology 63, 1175-1180.
26. Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Piacentini, S., Amaducci, L., Chumakov, I., Cohen, D., Lannfelt, L., Fraser, P.E., Rommens, J.M., St George-Hyslop, P.H., 1995. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
27. Rosenbloom, M.H., Alkalay, A., Agarwal, N., Baker, S.L., O'Neil, J.P., Janabi, M., Yen, I.V., Growdon, M., Jang, J., Madison, C., Mormino, E.C., Rosen, H.J., Gorno-Tempini, M.L., Weiner, M.W., Miller, B.L., Jagust, W.J., Rabinovici, G.D., 2011. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology 76, 1789-1796.
28. Rossi, G., Bastone, A., Piccoli, E., Morbin, M., Mazzoleni, G., Fugnanesi, V., Beeg, M., Del Favero, E., Cantu, L., Motta, S., Salsano, E., Pareyson, D., Erbetta, A., Elia, A.E., Del Sorbo, F., Silani, V., Morelli, C., Salmona, M., Tagliavini, F., 2014. Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features. Neurobiol. Aging 35, 408-417.
29. Saint-Aubert, L., Payoux, P., Hannequin, D., Barbeau, E.J., Campion, D., Delisle, M.B., Tafani, M., Viallard, G., Peran, P., Puel, M., Chollet, F., Demonet, J.F., Pariente, J., 2013. MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype. Alzheimer Dis. Assoc. Disord. 27, 91-94.
30. Sassi, C., Guerreiro, R., Gibbs, R., Ding, J., Lupton, M.K., Troakes, C., Al-Sarraj, S., Niblock, M., Gallo, J.M., Adnan, J., Killick, R., Brown, K.S., Medway, C., Lord, J., Turton, J., Bras, J., Morgan, K., Powell, J.F., Singleton, A., Hardy, J., 2014. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease. Neurobiol. Aging 35, 2881.e1-2881.e6.
31. Seguin, J., Formaglio, M., Perret-Liaudet, A., Quadrio, I., Tholance, Y., Rouaud, O., Thomas-Anterion, C., Croisile, B., Mollion, H., Moreaud, O., Salzmann, M., Dorey, A., Bataillard, M., Coste, M.H., Vighetto, A., Krolak-Salmon, P., 2011. CSF biomarkers in posterior cortical atrophy. Neurology 76, 1782-1788.
32. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.F., Bruni, A.C., Montesi, M.P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R.J., Wasco, W., Da Silva, H.A., Haines, J.L., Perkicak-Vance, M.A., Tanzi, R.E., Roses, A.D., Fraser, P.E., Rommens, J.M., St George-Hyslop, P.H., 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
33. Sitek, E.J., Narozanska, E., Peplonska, B., Filipek, S., Barczak, A., Styczynska, M., Mlynarczyk, K., Brockhuis, B., Portelius, E., Religa, D., Barcikowska, M., Slawek, J., Zekanowski, C., 2013. A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene. PLoS One 8, e61074.
34. Tang-Wai, D.F., Graff-Radford, N.R., Boeve, B.F., Dickson, D.W., Parisi, J.E., Crook, R., Caselli, R.J., Knopman, D.S., Petersen, R.C., 2004. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 63, 1168-1174.
35. Tremolizzo, L., Susani, E., Mapelli, C., Isella, V., Bertola, F., Ferrarese, C., Appollonio, I., 2015. First report of PSEN2 mutation presenting as posterior cortical atrophy. Alzheimer Dis. Assoc. Disord. 9, 249-251.
36. Victoroff, J., Ross, G.W., Benson, D.F., Verity, M.A., Vinters, H.V., 1994. Posterior cortical atrophy. Neuropathologic correlations. Arch. Neurol. 51, 269-274.
37. Wojtas, A., Heggeli, K.A., Finch, N., Baker, M., Dejesus-Hernandez, M., Younkin, S.G., Dickson, D.W., Graff-Radford, N.R., Rademakers, R., 2012. C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Am. J. Neurodegener. Dis. 1, 107-118.
38. Yu, J.T., Tan, L., Hardy, J., 2014. Apolipoprotein E in Alzheimer's disease: an update. Annu. Rev. Neurosci. 37, 79-100.